Celsion Return on Equity

Celsion (CLSN) currently reports a ROE of -5.6%. That is below the Healthcare sector average of 21.67%. Use the charts on this page to explore Celsion's ROE history and peer comparisons.

Celsion's ROE of -5.6% is lower than the Healthcare sector average of 21.67%. That is roughly 125.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Celsion's current -5.6% should be judged against Healthcare norms (sector average: 21.67%) and against CLSN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -5.6%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.67%. From there, open related valuation or income-statement pages for Celsion, and consider following CLSN for alerts when major investors trade the stock.

Celsion is classified in the Healthcare sector. On ROE, it currently shows -5.6% versus a sector average near 21.67%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLSN with unrelated industries.